We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$77.1B
AUM Growth
-$1.68B
(-2.1%)
Cap. Flow
-$2.68B
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Upbound Group
UPBD
$1.17B
| $10.8M | 0.01% |
596,702
+155,351
| +35% | +$3.03M |
|
952
CALL
Sysco
SYY
$40.6B
| $10.7M | 0.01% |
+150,000
| New | +$12.4M |
|
953
Protagonist Therapeutics
PTGX
$8.92B
| $10.7M | 0.01% |
+101,299
| New | +$8.97M |
|
954
LivaNova
LIVN
$4.45B
| $10.6M | 0.01% |
+167,300
| New | +$10.8M |
|
955
CALL
Vertex Pharmaceuticals
VRTX
$122B
| $10.6M | 0.01% |
23,700
+17,400
| +276% | +$8.11M |
|
956
New Oriental
EDU
$9B
| $10.6M | 0.01% |
186,369
+22,655
| +14% | +$1.29M |
|
|
CURB
957
Curbline Properties
CURB
$3.52B
| $10.5M | 0.01% |
408,778
-1,027,017
| -72% | -$26.3M |
|
958
Aflac
AFL
$64.8B
| $10.5M | 0.01% |
95,273
+79,168
| +492% | +$8.77M |
|
959
Summit Therapeutics
SMMT
$10.7B
| $10.4M | 0.01% |
548,335
+498,037
| +990% | +$8.05M |
|
960
CALL
Bank of America
BAC
$433B
| $10.4M | 0.01% |
212,400
-304,600
| -59% | -$15.7M |
|
961
PBF Energy
PBF
$8.67B
| $10.3M | 0.01% |
217,098
+195,835
| +921% | +$7.34M |
|
962
CALL
Lam Research
LRCX
$373B
| $10.3M | 0.01% |
48,300
-21,500
| -31% | -$4.81M |
|
963
PUT
Blackrock
BLK
$170B
| $10.3M | 0.01% |
10,700
+4,500
| +73% | +$4.73M |
|
964
PUT
Humana
HUM
$44B
| $10.3M | 0.01% |
59,200
+25,800
| +77% | +$5.29M |
|
965
Edgewell Personal Care
EPC
$1.26B
| $10.2M | 0.01% |
480,315
+338,839
| +240% | +$6.82M |
|
966
PUT
General Mills
GIS
$19.4B
| $10.2M | 0.01% |
+275,000
| New | +$11.9M |
|
967
PUT
Dollar Tree
DLTR
$24.7B
| $10.2M | 0.01% |
93,300
+71,500
| +328% | +$8.74M |
|
968
Goodyear
GT
$2.04B
| $10.2M | 0.01% |
+1,540,260
| New | +$13M |
|
|
XIFR
969
XPLR Infrastructure LP
XIFR
$1.12B
| $10.2M | 0.01% |
960,355
+109,492
| +13% | +$1.13M |
|
970
UFP Industries
UFPI
$4.87B
| $10.2M | 0.01% |
110,592
-102,728
| -48% | -$10.4M |
|
|
CRWV
971
CALL
CoreWeave
CRWV
$40.3B
| $10.2M | 0.01% |
131,100
+72,600
| +124% | +$6.3M |
|
972
CALL
State Street SPDR S&P Retail ETF
XRT
$453M
| $10.1M | 0.01% |
125,300
-597,300
| -83% | -$51.2M |
|
973
PUT
First Solar
FSLR
$22.1B
| $10.1M | 0.01% |
51,100
+34,500
| +208% | +$7.63M |
|
|
HLXC
974
Helix Acquisition Corp III
HLXC
$232M
| $10.1M | 0.01% |
+990,000
| New | +$10.1M |
|
975
PUT
Freeport-McMoran
FCX
$91.2B
| $10M | 0.01% |
170,700
-990,900
| -85% | -$59.9M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.
- Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
- Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.